(Commission File Number) | (IRS Employer Identification No.) | |
(Address of principal executive offices) | (Zip Code) | ||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Emerging Growth Company | |
☐ | If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
Item 2.02 | RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
Item 9.01 | FINANCIAL STATEMENTS AND EXHIBITS. |
EXHIBIT NUMBER | DESCRIPTION | |
99.1 | Press Release dated February 4, 2020 | |
99.2 | Earnings call slides dated February 4, 2020 | |
COLUMBUS McKINNON CORPORATION | |
By: | /s/ Gregory P. Rustowicz |
Name: | Gregory P. Rustowicz |
Title: | Vice President and Chief |
Financial Officer (Principal Financial Officer) | |
• | Blueprint for Growth strategy delivers strong operating results overcoming weaker industrial environment |
• | Gross margin expanded 20 basis points to 34.0%; Achieved 11th consecutive quarter of year-over-year expansion |
• | Diluted earnings per share was $0.63; adjusted diluted earnings per share increased $0.03 to $0.64 |
• | Cash from operations increased 24% to $32.4 million for the quarter and was up 31% year-to-date to $70.3 million |
($ in millions) | Q3 FY 20 | Q3 FY 19 | Change | % Change | ||||||||||
Net sales | $ | 199.4 | $ | 217.4 | $ | (18.1 | ) | (8.3 | )% | |||||
U.S. sales | $ | 108.4 | $ | 116.0 | $ | (7.6 | ) | (6.6 | )% | |||||
% of total | 54 | % | 53 | % | ||||||||||
Non-U.S. sales | $ | 91.0 | $ | 101.4 | $ | (10.4 | ) | (10.3 | )% | |||||
% of total | 46 | % | 47 | % | ||||||||||
($ in millions) | Q3 FY 20 | Q3 FY 19 | Change | % Change | ||||||||||
Gross profit | $ | 67.9 | $ | 73.4 | $ | (5.5 | ) | (7.5 | )% | |||||
Gross margin | 34.0 | % | 33.8 | % | 20 bps | |||||||||
Income from operations | $ | 20.9 | $ | 6.6 | $ | 14.2 | 214.3 | % | ||||||
Operating margin | 10.5 | % | 3.1 | % | 740 bps | |||||||||
Net income | $ | 15.3 | $ | (0.8 | ) | $ | 16.0 | NM | ||||||
Diluted EPS | $ | 0.63 | $ | (0.03 | ) | $ | 0.66 | NM | ||||||
Adjusted EBITDA * | $ | 30.4 | $ | 30.8 | $ | (0.4 | ) | (1.3 | )% | |||||
Adjusted EBITDA margin | 15.2 | % | 14.2 | % | 100 bps | |||||||||
Gregory P. Rustowicz | Investor Relations: |
Vice President - Finance and Chief Financial Officer | Deborah K. Pawlowski |
Columbus McKinnon Corporation | Kei Advisors LLC |
716-689-5442 | 716-843-3908 |
Three Months Ended | |||||||||||
December 31, 2019 | December 31, 2018 | Change | |||||||||
Net sales | $ | 199,355 | $ | 217,415 | (8.3 | )% | |||||
Cost of products sold | 131,483 | 144,010 | (8.7 | )% | |||||||
Gross profit | 67,872 | 73,405 | (7.5 | )% | |||||||
Gross profit margin | 34.0 | % | 33.8 | % | |||||||
Selling expenses | 23,169 | 23,858 | (2.9 | )% | |||||||
% of net sales | 11.6 | % | 11.0 | % | |||||||
General and administrative expenses | 17,960 | 20,379 | (11.9 | )% | |||||||
% of net sales | 9.0 | % | 9.4 | % | |||||||
Research and development expenses | 2,628 | 3,271 | (19.7 | )% | |||||||
% of net sales | 1.3 | % | 1.5 | % | |||||||
Net loss on sales of businesses, including impairment | — | 15,550 | NM | ||||||||
Amortization of intangibles | 3,229 | 3,701 | (12.8 | )% | |||||||
Income from operations | 20,886 | 6,646 | 214.3 | % | |||||||
Operating margin | 10.5 | % | 3.1 | % | |||||||
Interest and debt expense | 3,423 | 4,330 | (20.9 | )% | |||||||
Investment (income) loss | (408 | ) | 82 | NM | |||||||
Foreign currency exchange (gain) loss | 188 | (25 | ) | NM | |||||||
Other (income) expense, net | 199 | (70 | ) | NM | |||||||
Income before income tax expense | 17,484 | 2,329 | 650.7 | % | |||||||
Income tax expense | 2,234 | 3,111 | (28.2 | )% | |||||||
Net income (loss) | $ | 15,250 | $ | (782 | ) | NM | |||||
Average basic shares outstanding | 23,679 | 23,348 | 1.4 | % | |||||||
Basic income (loss) per share | $ | 0.64 | $ | (0.03 | ) | NM | |||||
Average diluted shares outstanding | 24,031 | 23,348 | 2.9 | % | |||||||
Diluted income (loss) per share | $ | 0.63 | $ | (0.03 | ) | NM | |||||
Dividends declared per common share | $ | 0.06 | $ | 0.05 | |||||||
Nine Months Ended | |||||||||||
December 31, 2019 | December 31, 2018 | Change | |||||||||
Net sales | $ | 619,676 | $ | 659,549 | (6.0 | )% | |||||
Cost of products sold | 402,699 | 430,597 | (6.5 | )% | |||||||
Gross profit | 216,977 | 228,952 | (5.2 | )% | |||||||
Gross profit margin | 35.0 | % | 34.7 | % | |||||||
Selling expenses | 68,801 | 73,940 | (7.0 | )% | |||||||
% of net sales | 11.1 | % | 11.2 | % | |||||||
General and administrative expenses | 56,713 | 61,893 | (8.4 | )% | |||||||
% of net sales | 9.2 | % | 9.4 | % | |||||||
Research and development expenses | 8,419 | 10,137 | (16.9 | )% | |||||||
% of net sales | 1.4 | % | 1.5 | % | |||||||
Net loss on sales of businesses, including impairment | 176 | 26,650 | (99.3 | )% | |||||||
Amortization of intangibles | 9,708 | 11,358 | (14.5 | )% | |||||||
Income from operations | 73,160 | 44,974 | 62.7 | % | |||||||
Operating margin | 11.8 | % | 6.8 | % | |||||||
Interest and debt expense | 11,034 | 13,185 | (16.3 | )% | |||||||
Investment (income) loss | (939 | ) | (297 | ) | 216.2 | % | |||||
Foreign currency exchange (gain) loss | (518 | ) | 206 | NM | |||||||
Other (income) expense, net | 618 | (417 | ) | NM | |||||||
Income before income tax expense | 62,965 | 32,297 | 95.0 | % | |||||||
Income tax expense | 12,537 | 9,461 | 32.5 | % | |||||||
Net income | $ | 50,428 | $ | 22,836 | 120.8 | % | |||||
Average basic shares outstanding | 23,581 | 23,245 | 1.4 | % | |||||||
Basic income per share | $ | 2.14 | $ | 0.98 | 118.4 | % | |||||
Average diluted shares outstanding | 23,925 | 23,647 | 1.2 | % | |||||||
Diluted income per share | $ | 2.11 | $ | 0.97 | 117.5 | % | |||||
Dividends declared per common share | $ | 0.12 | $ | 0.10 | |||||||
December 31, 2019 | March 31, 2019 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 84,014 | $ | 71,093 | ||||
Trade accounts receivable | 125,386 | 129,157 | ||||||
Inventories | 135,449 | 146,263 | ||||||
Prepaid expenses and other | 16,890 | 16,075 | ||||||
Total current assets | 361,739 | 362,588 | ||||||
Property, plant, and equipment, net | 81,117 | 87,303 | ||||||
Goodwill | 322,766 | 322,816 | ||||||
Other intangibles, net | 223,206 | 232,940 | ||||||
Marketable securities | 7,370 | 7,028 | ||||||
Deferred taxes on income | 25,117 | 27,707 | ||||||
Other assets | 58,544 | 21,189 | ||||||
Total assets | $ | 1,079,859 | $ | 1,061,571 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Trade accounts payable | $ | 46,317 | $ | 46,974 | ||||
Accrued liabilities | 94,205 | 99,304 | ||||||
Current portion of long-term debt | 65,000 | 65,000 | ||||||
Total current liabilities | 205,522 | 211,278 | ||||||
Term loan and revolving credit facility | 186,893 | 235,320 | ||||||
Other non-current liabilities | 203,078 | 183,814 | ||||||
Total liabilities | 595,493 | 630,412 | ||||||
Shareholders’ equity: | ||||||||
Common stock | 237 | 234 | ||||||
Additional paid-in capital | 284,842 | 277,518 | ||||||
Retained earnings | 284,047 | 236,459 | ||||||
Accumulated other comprehensive loss | (84,760 | ) | (83,052 | ) | ||||
Total shareholders’ equity | 484,366 | 431,159 | ||||||
Total liabilities and shareholders’ equity | $ | 1,079,859 | $ | 1,061,571 | ||||
Nine Months Ended | ||||||||
December 31, 2019 | December 31, 2018 | |||||||
Operating activities: | ||||||||
Net income | $ | 50,428 | $ | 22,836 | ||||
Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||||||
Depreciation and amortization | 21,991 | 24,763 | ||||||
Deferred income taxes and related valuation allowance | 1,247 | (2,353 | ) | |||||
Net loss (gain) on sale of real estate, investments, and other | (602 | ) | 109 | |||||
Stock based compensation | 3,510 | 4,625 | ||||||
Amortization of deferred financing costs | 1,782 | 1,992 | ||||||
Net loss on sales of businesses, including impairment | 176 | 26,650 | ||||||
Non-cash lease expense | 6,136 | — | ||||||
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures: | ||||||||
Trade accounts receivable | 3,989 | (1,407 | ) | |||||
Inventories | 10,870 | (13,043 | ) | |||||
Prepaid expenses and other | (3,224 | ) | (103 | ) | ||||
Other assets | 726 | 232 | ||||||
Trade accounts payable | (3,013 | ) | (5,330 | ) | ||||
Accrued liabilities | (11,458 | ) | 3,558 | |||||
Non-current liabilities | (12,306 | ) | (8,733 | ) | ||||
Net cash provided by (used for) operating activities | 70,252 | 53,796 | ||||||
Investing activities: | ||||||||
Proceeds from sales of marketable securities | 4,908 | 1,238 | ||||||
Purchases of marketable securities | (4,961 | ) | (835 | ) | ||||
Capital expenditures | (6,761 | ) | (7,236 | ) | ||||
Proceeds from sale of equipment and real estate | 51 | 176 | ||||||
Net (payments) proceeds from sales of businesses | (214 | ) | 5,103 | |||||
Payment of restricted cash to former owner | — | (294 | ) | |||||
Net cash provided by (used for) investing activities | (6,977 | ) | (1,848 | ) | ||||
Financing activities: | ||||||||
Proceeds from the issuance of common stock | 4,457 | 3,708 | ||||||
Repayment of debt | (50,000 | ) | (50,051 | ) | ||||
Payment of dividends | (4,245 | ) | (3,484 | ) | ||||
Other | (643 | ) | (1,941 | ) | ||||
Net cash provided by (used for) financing activities | (50,431 | ) | (51,768 | ) | ||||
Effect of exchange rate changes on cash | 77 | (5,416 | ) | |||||
Net change in cash and cash equivalents | 12,921 | (5,236 | ) | |||||
Cash, cash equivalents, and restricted cash at beginning of year | 71,343 | 63,565 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 84,264 | $ | 58,329 | ||||
Quarter | Year To Date | |||||||||||||
($ in millions) | $ Change | % Change | $ Change | % Change | ||||||||||
Fiscal 2019 Sales | $ | 217.4 | $ | 659.5 | ||||||||||
Divestitures | (9.0 | ) | (29.3 | ) | ||||||||||
Fiscal 2019 Sales adjusted for divestitures | $ | 208.4 | $ | 630.2 | ||||||||||
Volume | (10.6 | ) | (5.2 | )% | (10.0 | ) | (1.6 | )% | ||||||
Pricing | 3.3 | 1.6 | % | 10.3 | 1.6 | % | ||||||||
Foreign currency translation | (1.7 | ) | (0.8 | )% | (10.8 | ) | (1.7 | )% | ||||||
Total change adjusted for divestitures | $ | (9.0 | ) | (4.4 | )% | $ | (10.5 | ) | (1.7 | )% | ||||
Fiscal 2020 Sales | $ | 199.4 | $ | 619.7 | ||||||||||
($ in millions) | Quarter | Year To Date | |||||
Fiscal 2019 Gross Profit | $ | 73.4 | $ | 229.0 | |||
Divestitures | (2.0 | ) | (6.1 | ) | |||
Fiscal 2019 Gross Profit adjusted for divestitures | 71.4 | 222.9 | |||||
Pricing, net of material cost inflation | 2.8 | 7.9 | |||||
Insurance settlement | 0.1 | 0.4 | |||||
Business realignment costs | (0.1 | ) | — | ||||
Product liability | (0.1 | ) | (0.3 | ) | |||
Tariffs | 0.1 | (1.2 | ) | ||||
Factory closures | (0.5 | ) | (1.3 | ) | |||
Productivity, net of other cost changes | (2.2 | ) | (1.9 | ) | |||
Foreign currency translation | (0.6 | ) | (3.7 | ) | |||
Sales volume and mix | (3.0 | ) | (5.8 | ) | |||
Total change adjusted for divestitures | $ | (3.5 | ) | $ | (5.9 | ) | |
Fiscal 2020 Gross Profit | $ | 67.9 | $ | 217.0 | |||
December 31, 2019 | September 30, 2019 | December 31, 2018 | |||||||||||||
($ in millions) | |||||||||||||||
Backlog | $ | 125.3 | $ | 143.1 | $ | 159.9 | |||||||||
Backlog excluding divestitures | $ | 125.3 | $ | 143.1 | $ | 154.4 | |||||||||
Long-term backlog | |||||||||||||||
Expected to ship beyond 3 months | $ | 51.3 | $ | 53.9 | $ | 55.1 | |||||||||
Long-term backlog as % of total backlog | 40.9 | % | 37.7 | % | 34.5 | % | |||||||||
Trade accounts receivable | |||||||||||||||
Days sales outstanding | 57.2 | days | 57.0 | days | 52.3 | days | |||||||||
Inventory turns per year | |||||||||||||||
(based on cost of products sold) | 3.9 | turns | 3.8 | turns | 3.8 | turns | |||||||||
Days' inventory | 94.0 | days | 96.9 | days | 96.1 | days | |||||||||
Trade accounts payable | |||||||||||||||
Days payables outstanding | 32.1 | days | 33.2 | days | 25.4 | days | |||||||||
Working capital as a % of sales (1) | 16.5 | % | 17.2 | % | 17.9 | % | |||||||||
Debt to total capitalization percentage | 34.2 | % | 36.9 | % | 42.8 | % | |||||||||
Debt, net of cash, to net total capitalization | 25.7 | % | 30.1 | % | 37.9 | % | |||||||||
U.S. Shipping Days by Quarter | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
FY 20 | 63 | 63 | 61 | 64 | 251 | |||||
FY 19 | 64 | 63 | 60 | 63 | 250 | |||||
Three Months Ended December 31, | Year To Date December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Gross profit | $ | 67,872 | $ | 73,405 | $ | 216,977 | $ | 228,952 | |||||||
Add back (deduct): | |||||||||||||||
Factory closures | 696 | 200 | 1,451 | 200 | |||||||||||
Business realignment costs | 123 | — | 263 | — | |||||||||||
Insurance settlement | (77 | ) | — | (367 | ) | — | |||||||||
Non-GAAP adjusted gross profit | $ | 68,614 | $ | 73,605 | $ | 218,324 | $ | 229,152 | |||||||
Sales | $ | 199,355 | $ | 217,415 | $ | 619,676 | $ | 659,549 | |||||||
Adjusted gross margin | 34.4 | % | 33.9 | % | 35.2 | % | 34.7 | % | |||||||
Three Months Ended December 31, | Year To Date December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Income from operations | $ | 20,886 | $ | 6,646 | $ | 73,160 | $ | 44,974 | |||||||
Add back (deduct): | |||||||||||||||
Factory closures | 1,592 | 200 | 3,089 | 200 | |||||||||||
Business realignment costs | 662 | — | 1,075 | 1,906 | |||||||||||
Insurance recovery legal costs | 66 | 491 | 425 | 1,150 | |||||||||||
Net loss on sales of businesses, including impairment | — | 15,550 | 176 | 26,650 | |||||||||||
Insurance settlement | (77 | ) | — | (367 | ) | — | |||||||||
Non-GAAP adjusted income from operations | $ | 23,129 | $ | 22,887 | $ | 77,558 | $ | 74,880 | |||||||
Sales | $ | 199,355 | $ | 217,415 | $ | 619,676 | $ | 659,549 | |||||||
Adjusted operating margin | 11.6 | % | 10.5 | % | 12.5 | % | 11.4 | % | |||||||
Three Months Ended December 31, | Year To Date December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net income (loss) | $ | 15,250 | $ | (782 | ) | $ | 50,428 | $ | 22,836 | ||||||
Add back (deduct): | |||||||||||||||
Factory closures | 1,592 | 200 | 3,089 | 200 | |||||||||||
Business realignment costs | 662 | — | 1,075 | 1,906 | |||||||||||
Insurance recovery legal costs | 66 | 491 | 425 | 1,150 | |||||||||||
Net loss on sales of businesses, including impairment | — | 15,550 | 176 | 26,650 | |||||||||||
Insurance settlement | (77 | ) | — | (367 | ) | — | |||||||||
Normalize tax rate to 22% (1) | (2,106 | ) | (974 | ) | (2,283 | ) | (4,224 | ) | |||||||
Non-GAAP adjusted net income | $ | 15,387 | $ | 14,485 | $ | 52,543 | $ | 48,518 | |||||||
Average diluted shares outstanding | 24,031 | 23,681 | 23,925 | 23,647 | |||||||||||
Diluted income per share - GAAP | $ | 0.63 | $ | (0.03 | ) | $ | 2.11 | $ | 0.97 | ||||||
Diluted income per share - Non-GAAP | $ | 0.64 | $ | 0.61 | $ | 2.20 | $ | 2.05 | |||||||
Three Months Ended December 31, | Year To Date December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net income (loss) | $ | 15,250 | $ | (782 | ) | $ | 50,428 | $ | 22,836 | ||||||
Add back (deduct): | |||||||||||||||
Income tax expense | 2,234 | 3,111 | 12,537 | 9,461 | |||||||||||
Interest and debt expense | 3,423 | 4,330 | 11,034 | 13,185 | |||||||||||
Investment (income) loss | (408 | ) | 82 | (939 | ) | (297 | ) | ||||||||
Foreign currency exchange (gain) loss | 188 | (25 | ) | (518 | ) | 206 | |||||||||
Other (income) expense, net | 199 | (70 | ) | 618 | (417 | ) | |||||||||
Depreciation and amortization expense | 7,244 | 7,901 | 21,991 | 24,763 | |||||||||||
Factory closures | 1,592 | 200 | 3,089 | 200 | |||||||||||
Business realignment costs | 662 | — | 1,075 | 1,906 | |||||||||||
Insurance recovery legal costs | 66 | 491 | 425 | 1,150 | |||||||||||
Net loss on sales of businesses, including impairment | — | 15,550 | 176 | 26,650 | |||||||||||
Insurance settlement | (77 | ) | — | (367 | ) | — | |||||||||
Non-GAAP adjusted EBITDA | $ | 30,373 | $ | 30,788 | $ | 99,549 | $ | 99,643 | |||||||
Sales | $ | 199,355 | $ | 217,415 | $ | 619,676 | $ | 659,549 | |||||||
Adjusted EBITDA margin | 15.2 | % | 14.2 | % | 16.1 | % | 15.1 | % | |||||||